Financial Advisors Network, Inc. Amgen Inc Transaction History

Financial Advisors Network, Inc.

$496 Million
Q4 2023

A detailed history of Financial Advisors Network, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Financial Advisors Network, Inc. holds 1,440 shares of AMGN stock, worth $460,195. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,440

Previous 1,451 0.76%

Holding current value

$460,195

Previous $389,000 6.43%

% of portfolio

0.08%

Previous 0.09%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $2,812 - $3,173	-11 Reduced 0.76%	1,440 $414,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $317,261 - $393,888	1,451 New	1,451 $389,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $252,599 - $279,440	-1,152 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $6,165 - $7,055	31 Added 2.77%	1,152 $259,000
Q3 2021 Dec 27, 2021	BUY	$212.27 - $248.7 $38,845 - $45,512	183 Added 19.51%	1,121 $237,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $13,781 - $15,289	59 Added 6.71%	938 $229,000
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $195,058 - $227,309	879 New	879 $219,000
Q1 2019 Jun 04, 2019	SELL	$180.87 - $203.88 $421,969 - $475,652	-2,333 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $399,018 - $448,183	-2,403 Reduced 50.74%	2,333 $431,000
Q4 2017 Feb 07, 2018	BUY	$168.79 - $188.59 $337 - $377	2 Added 0.04%	4,736 $824,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $791,950 - $904,194	4,734	4,734 $883,000

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advisors Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Advisors Network, Inc. with notifications on news.

Account

Financial Advisors Network, Inc. Amgen Inc Transaction History